Indivior PLC to Acquire Opiant Pharmaceuticals Inc Call Transcript
Good day, and thank you for standing by. Welcome to the Indivior Acquisition of Opiant Pharmaceuticals Conference Call. (Operator Instructions)
Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Mark Crossley, CEO. Please go ahead.
Thank you, Sandra, and good morning, and good afternoon, everyone. Thank you for joining us on such short notice to discuss an exciting development for our company. I'm joined by Ryan Preblick, our Chief Financial Officer; and Christian Heidbreder, our Chief Scientific Officer.
I'll briefly cover the highlights of the transaction we announced today, and then Ryan will cover off the financial aspects and closing conditions, after which we'll open it up for questions and answers. I'd ask that you each please read in full the information on Pages 2 and 3 of the presentation as it is important.
Earlier today, we announced a definitive agreement to acquire Opiant
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |